enov.one
About enov.one
Enovone offers personalized telemedicine services, focusing on enhancing individual well-being through customized health programs. The company's approach integrates genetic data, blood biomarkers, wearable device metrics, and medical interviews to develop tailored treatment plans. These plans address various health aspects, including sleep quality, nutrition, metabolic function, hormonal balance, immune response, cognitive performance, and lifestyle optimization. It provides injectable treatments such as NAD+, B12, and glutathione, compounded by U.S.-based pharmacies and delivered directly to clients. The company employs a "tripod approach," combining genetic analysis, blood testing, and medical interviews to uncover the root causes of health issues. Clients begin with a brief online assessment, followed by consultations with healthcare professionals who design and monitor individualized health plans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Jan 2024)
- Website: enov.one
- Phone: 833-828-5216
Social Profiles
Canonical: https://fsome.com/organization/enov-one-2584423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.